Dexcom taps Garmin for first real-time API integration
In July, Dexcom got FDA clearance to allow third parties to access its CGM data. To start, it is integrating with Garmin’s wearable devices.
Dexcom finds CGM use helps people with Type 2 diabetes stay in range
The company recently published new results on its MOBILE study, which found that CGM use increased time in range for people with Type 2 diabetes. New data shows people who stopped using a CGM saw time in range decrease.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Dexcom’s CEO claims company has a ‘compelling’ case for broader CGM use
In a wide-ranging interview, Dexcom’s CEO shared more about the company’s push to prove its continuous glucose monitor can be used both for patients with Type 1 and Type 2 diabetes, and how the device-maker is handling a growing number of competitors.
Dexcom launches first VC fund
Dexcom launched its first venture fund. The company, which makes continuous glucose monitors, plans to invest in glucose sensing technologies and metabolic monitoring.
UnitedHealth creates its own digital health program for type 2 diabetes
The company is rolling out Level2, a digital health program for patients with type 2 diabetes. It uses wearable devices and coaches to help users manage their health.
Abbott gets FDA clearance for newest CGM
Abbott Laboratories received FDA clearance for its newest continuous glucose monitor, the FreeStyle Libre 2. The product is one of many in a growing market for CGMs.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
At JPM, Dexcom’s CEO says he is exploring options to sell directly to consumers
In an interview at the J.P. Morgan Healthcare Conference in San Francisco earlier this week, the CEO of Dexcom relayed a strong desire to sell CGM systems directly to the consumers with possible pilots this year.
Livongo’s stock slightly higher after president talks about Dexcom partnership
Livongo and Dexcom struck a partnership on Monday that would combine Dexcom’s continuous glucose monitors with Livongo’s software. At the StartUp Health Conference, Livongo President Jennifer Schneider said its work with Dexcom would create a new stream of data for both companies.
Bigfoot Biomedical lands $45M as it readies first diabetes product
The money will help the company launch its first insulin-management product by the end of this year, which is likely to face stiff competition from larger rivals.
Dexcom and Livongo partner to allow glucose data to be synced on Livongo platform
Medical device maker Dexcom is partnering with Livongo such that users of Livongo that have diabetes and use Dexcom's continuous glucose monitoring system can sync their data on the Livongo platform.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Tandem Diabetes snags FDA approval for interoperable insulin pump software
Tandem Diabetes’ technology will create a new approval pathway for predictive dosing software that can be used with other devices.
Dexcom’s IT outage shows fabulous device maker floundering with patient communication
Scores of users took to Facebook to express their dismay, frustration and anger at Dexcom when the CGM device company failed to properly keep them updated after an IT outage prevented type 1 diabetes patients from sharing data.
Walgreens bolsters digital marketplace with new chronic disease management tools
Find Care, which was launched one year ago, was initially started to help patients find and identify location specific healthcare services through the Walgreens app and website.
When it comes to diabetes devices and apps, FDA prefers mixing and matching
On the day that an FDA official exhorts industry to develop interoperable diabetes devices, Medtronic announces that it is teaming up with a nonprofit group to do just that.
Connected device research platform Fitabase signs integration deal with Dexcom
Fitabase CEO Aaron Coleman said he sees the integration being particularly useful to researchers looking at how behavioral recommendations in areas like physical activity and sleep can affect glucose levels to create more tailored care plans for diabetic patients.